Raykov Rosty's Form 4 filing
Fennec Pharmaceuticals Inc. (FENC) · filed Jan 7, 2025
- Accession no.
- 0001415889-25-001014
- Filed
- Jan 7, 2025
- Trade date
- Jan 6, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $60.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Raykov RostyCIK 0001468316 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | Common shares | SSaleDisposed | −2,431 | $6.08 | −$14,780.48 | 91,432 | Direct | |
| Jan 6, 2025 | Common shares | SSaleDisposed | −7,569 | $6.08 | −$46,019.52 | 83,863 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.